Mark A. Massa

676 total citations
19 papers, 485 citations indexed

About

Mark A. Massa is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Mark A. Massa has authored 19 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Mark A. Massa's work include Chemical Synthesis and Analysis (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Metal complexes synthesis and properties (3 papers). Mark A. Massa is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Metal complexes synthesis and properties (3 papers). Mark A. Massa collaborates with scholars based in United States. Mark A. Massa's co-authors include Bingwei Yang, Joyce A. Sutcliffe, L Wondrack, Thomas B. Rauchfuss, Scott R. Wilson, James A. Sikorski, Justin B. Sperry, Keshab Bhattacharya, Daniel T. Connolly and Mark E. Smith and has published in prestigious journals such as Journal of the American Chemical Society, Chemistry of Materials and Journal of Medicinal Chemistry.

In The Last Decade

Mark A. Massa

19 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Massa United States 13 204 152 75 64 55 19 485
Susan K. Hendges United States 6 387 1.9× 294 1.9× 257 3.4× 47 0.7× 30 0.5× 6 766
Peter R. Manninen United States 7 398 2.0× 291 1.9× 223 3.0× 45 0.7× 21 0.4× 10 775
Zijian Liu China 16 283 1.4× 293 1.9× 69 0.9× 44 0.7× 27 0.5× 44 646
Giulia Martelli Italy 16 414 2.0× 419 2.8× 28 0.4× 44 0.7× 28 0.5× 51 983
Sabesan Yoganathan United States 15 184 0.9× 323 2.1× 50 0.7× 18 0.3× 49 0.9× 32 693
Núria Blanco‐Cabra Spain 14 119 0.6× 249 1.6× 30 0.4× 37 0.6× 17 0.3× 25 587
Paula Carolina de Souza Brazil 11 189 0.9× 87 0.6× 54 0.7× 36 0.6× 13 0.2× 18 429
Pål Rongved Norway 15 269 1.3× 296 1.9× 40 0.5× 30 0.5× 30 0.5× 37 717
P.C Sathler Brazil 16 246 1.2× 147 1.0× 44 0.6× 12 0.2× 20 0.4× 39 571
Raoni S. B. Gonçalves Brazil 14 494 2.4× 227 1.5× 107 1.4× 228 3.6× 26 0.5× 42 912

Countries citing papers authored by Mark A. Massa

Since Specialization
Citations

This map shows the geographic impact of Mark A. Massa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Massa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Massa more than expected).

Fields of papers citing papers by Mark A. Massa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Massa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Massa. The network helps show where Mark A. Massa may publish in the future.

Co-authorship network of co-authors of Mark A. Massa

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Massa. A scholar is included among the top collaborators of Mark A. Massa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Massa. Mark A. Massa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sperry, Justin B., Qin Zou, Qing Chang, et al.. (2018). Effects of Conformational Changes in Peptide–CRM197 Conjugate Vaccines. Bioconjugate Chemistry. 30(1). 47–53. 15 indexed citations
2.
Liao, Xiaoli, Keshab Bhattacharya, Justin B. Sperry, et al.. (2016). Systematic Investigation of EDC/sNHS-Mediated Bioconjugation Reactions for Carboxylated Peptide Substrates. Bioconjugate Chemistry. 27(4). 994–1004. 85 indexed citations
3.
Wang, Jane L., et al.. (2004). 3-Methyl-4H-[1,2,4]-oxadiazol-5-one: a versatile synthon for protecting monosubstituted acetamidines. Tetrahedron. 60(48). 10907–10914. 10 indexed citations
4.
Sexton, Karen E., Helen T. Lee, Mark A. Massa, et al.. (2003). Inhibitors of lipoprotein(a) assembly. Bioorganic & Medicinal Chemistry. 11(22). 4827–4845. 6 indexed citations
5.
Reinhard, Emily J., Jane L. Wang, Richard C. Durley, et al.. (2003). Discovery of a Simple Picomolar Inhibitor of Cholesteryl Ester Transfer Protein. Journal of Medicinal Chemistry. 46(11). 2152–2168. 42 indexed citations
6.
Durley, Richard C., Mark A. Massa, Jane L. Wang, et al.. (2002). Chiral N,N-Disubstituted Trifluoro-3-Amino-2-Propanols Are Potent Inhibitors of Cholesteryl Ester Transfer Protein. Journal of Medicinal Chemistry. 45(18). 3891–3904. 20 indexed citations
7.
Massa, Mark A., Dale Spangler, Richard C. Durley, et al.. (2001). Novel heteroaryl replacements of aromatic 3-tetrafluoroethoxy substituents in trifluoro-3-(tertiaryamino)-2-propanols as potent inhibitors of cholesteryl ester transfer protein. Bioorganic & Medicinal Chemistry Letters. 11(13). 1625–1628. 43 indexed citations
8.
9.
Massa, Mark A., Barnett S. Pitzele, Gina Jerome, et al.. (2000). Syntheses of new racemicNG-(1-iminoethyl)phosphalysine derivatives as potential inhibitors of nitric oxide synthase. Heteroatom Chemistry. 11(7). 505–511. 2 indexed citations
10.
Durley, Richard C., Mark A. Massa, Deborah A. Mischke, et al.. (2000). Discovery of Chiral N,N-Disubstituted Trifluoro-3-amino-2-propanols as Potent Inhibitors of Cholesteryl Ester Transfer Protein. Journal of Medicinal Chemistry. 43(24). 4575–4578. 23 indexed citations
11.
Patt, William C., Xue‐Min Cheng, Joseph T. Repine, et al.. (1999). Butenolide Endothelin Antagonists with Improved Aqueous Solubility. Journal of Medicinal Chemistry. 42(12). 2162–2168. 14 indexed citations
12.
Massa, Mark A., et al.. (1998). Synthesis of novel substituted pyridines as inhibitors of endothelin coverting enzyme-1 (ECE-1). Bioorganic & Medicinal Chemistry Letters. 8(16). 2117–2122. 7 indexed citations
13.
Massa, Mark A., et al.. (1998). Functionalization of Cp4Fe4(CO)4:  Contrasts and Comparisons with Ferrocene. Journal of the American Chemical Society. 120(1). 114–123. 33 indexed citations
14.
Patt, William C. & Mark A. Massa. (1997). The total synthesis of the natural product endothelin converting enzyme (ECE) inhibitor, WS75624 B. Tetrahedron Letters. 38(8). 1297–1300. 12 indexed citations
15.
Yang, Bingwei & Mark A. Massa. (1996). Synthesis of 3‘‘-Desmethoxyazithromycin:  Regioselectivity and Stereoselectivity of SmI2-Mediated α-Deoxygenation Reaction. The Journal of Organic Chemistry. 61(15). 5149–5152. 5 indexed citations
16.
Wondrack, L, Mark A. Massa, Bingwei Yang, & Joyce A. Sutcliffe. (1996). Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrobial Agents and Chemotherapy. 40(4). 992–998. 106 indexed citations
17.
Massa, Mark A., Thomas B. Rauchfuss, & Scott R. Wilson. (1991). A unidentate thiometalate complex: (MeCp)(dppe)Ru-S-ReS3 [bis(diphenylphosphinoethane][methyl cyclopentadienyl-.mu.-sulfidotrisulfidorheniumruthenium]. Inorganic Chemistry. 30(24). 4667–4669. 13 indexed citations
18.
Massa, Mark A. & Thomas B. Rauchfuss. (1991). Synthesis of the functionalized cluster (CH:CH2C5H4)Cp3Fe4(CO)4 and its incorporation into poly(methyl methacrylate). Chemistry of Materials. 3(5). 788–790. 12 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan K. Hendges Breakdown of academic impact, for papers by Peter R. Manninen Breakdown of academic impact, for papers by Zijian Liu Breakdown of academic impact, for papers by Giulia Martelli Breakdown of academic impact, for papers by Sabesan Yoganathan Breakdown of academic impact, for papers by Núria Blanco‐Cabra Breakdown of academic impact, for papers by Paula Carolina de Souza Breakdown of academic impact, for papers by Pål Rongved Breakdown of academic impact, for papers by P.C Sathler Breakdown of academic impact, for papers by Raoni S. B. Gonçalves
Rankless by CCL
2026